Interleukin-6 as a therapy target in oral squamous carcinoma

ISSN： 1472-8222

Source： Expert Opinion on Therapeutic Targets, Vol.17, Iss.1, 2013-01, pp. : 53-59

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Photodynamic therapy with HPPH is promising in the treatment of oral squamous cell carcinoma

Inpharma, Vol. 1, Iss. 1234, 2000-01 ,pp. : 9-9

Adis International

Access to resources Recommend Favorite

Interleukin-6/interleukin-6 Receptor Pathway as a New Therapy Target in Epithelial Ovarian Cancer

Current Pharmaceutical Design, Vol. 18, Iss. 25, 2012-07 ,pp. : 3816-3827

Bentham Science Publishers

Access to resources Recommend Favorite

Thymidine Phosphorylase Over-Expression in Oral Squamous Carcinoma Tissue as a Potential Target of Capecitabine

Letters in Drug Design & Discovery, Vol. 1, Iss. 1, 2004-01 ,pp. : 45-49

Bentham Science Publishers

Access to resources Recommend Favorite

Azathioprine: Oral squamous cell carcinoma: case report

Reactions Weekly, Vol. 1, Iss. 1418, 2012-01 ,pp. : 12-13

Adis International

Access to resources Recommend Favorite

Taxol: Efficacy Against Oral Squamous Cell Carcinoma

Mini Reviews in Medicinal Chemistry, Vol. 13, Iss. 4, 2013-04 ,pp. : 509-521

Bentham Science Publishers

Access to resources Recommend Favorite